Patents by Inventor Haili LV

Haili LV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230235057
    Abstract: Provided in the present disclosure are a bifunctional protein which can bind to PD-1 (programmed death receptor-1) and TGF-? (transforming growth factor-?), the medical use of the bifunctional protein, and a preparation method therefor.
    Type: Application
    Filed: April 26, 2021
    Publication date: July 27, 2023
    Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: WEI ZHAO, YINGCHUN Ll, HAILI LV, LIANXIANG XIE, ZHEWEN ZHANG, YU QIN, XIQUAN ZHANG, YANJU CHENG, PENG LV, TIANTIAN LI
  • Publication number: 20220289825
    Abstract: Provided are a fusion protein targeting PD-L1 and TGF-? and use thereof. The fusion protein is a fusion protein comprising an antibody or antigen-binding fragment that specifically binds to human PD-L1 and a human TGF?RII binding domain. Further provided are a polynucleotide encoding the fusion protein, a host cell containing the polynucleotide, and the use of the fusion protein in the preparation of an anti-tumor drug.
    Type: Application
    Filed: August 28, 2020
    Publication date: September 15, 2022
    Inventors: Wei ZHAO, Yingchun LI, Lianxiang XIE, Yamin LU, Haili LV, Xiuzhen DU, Tongjie XU, Yanju CHENG, Xiquan ZHANG